ArriVent BioPharma, Inc. (AVBP) stock

AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$13.01−0.06 (-0.46%)

Close on Nov 13, 2026Market cap $641.49MP/E –Yield –

ArriVent BioPharma gross margin

Gross margin is gross profit as a percentage of revenue.

ArriVent BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?